A 60-kD protein mediates the binding of transforming growth factor-beta to cell surface and extracellular matrix proteoglycans
Open Access
- 1 August 1993
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 122 (3) , 721-727
- https://doi.org/10.1083/jcb.122.3.721
Abstract
The biological activity of many cytokines is regulated by binding proteins present at the cell surface, in extracellular matrices or in soluble phase. We describe here a TGF-beta binding protein that is both an extracellular matrix and a cell surface protein. When intact extracellular matrices of HEP-G2 cells were affinity cross-linked with 125I-TGF-beta 1, two major binding components were seen: a 250-kD, proteoglycan-like molecule, presumed to be betaglycan, and a 60-kD protein. The 60-kD TGF-beta-binding protein was also present at the cell surface. It could be released from the cell surface by treating cells with high salt, heparin, chondroitin sulfate, heparitinase, or chondroitinase, indicating that it is bound to heparan sulfate and chondroitin sulfate proteoglycans. The 60-kD protein bound TGF-beta 1 with an apparent dissociation constant of 1.6 nM, and there were 30,000 binding sites per cell at the cell surface. In addition to the HEP-G2 cells and another hepatoma cell line, the 60-kD protein was also found in a human colon carcinoma (HT-29) cell line but not in rat kidney (NRK-49F) or human fibroblast (HUT-12) cell lines. The 60-kD protein could be extracted from cells containing it and transferred to the surface of previously negative cells. The 60-kD protein may serve to regulate the binding of TGF-beta to its signal transducing receptors by targeting TGF-beta to appropriate locations in the microenvironment of cells.Keywords
This publication has 41 references indexed in Scilit:
- Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.Proceedings of the National Academy of Sciences, 1993
- Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone.Journal of Biological Chemistry, 1987
- Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools.Molecular and Cellular Biology, 1987
- Fibronectin‐associated transforming growth factorJournal of Cellular Physiology, 1987
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.Proceedings of the National Academy of Sciences, 1986
- REVERSIBLE INHIBITION OF NORMAL HUMAN PROKERATINOCYTE PROLIFERATION BY TYPE-BETA TRANSFORMING GROWTH FACTOR-GROWTH INHIBITOR IN SERUM-FREE MEDIUM1986
- Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.Proceedings of the National Academy of Sciences, 1986
- Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.Journal of Biological Chemistry, 1986
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970